Serotonin reduction in post-acute sequelae of viral infection

The study titled “Serotonin Reduction in Post-Acute Sequelae of Viral Infection” explores the mechanisms and consequences of serotonin reduction in individuals with Post-Acute Sequelae of COVID-19 (PASC), also known as Long COVID. The main findings of the study are as follows: Overall, the study provides a comprehensive analysis of how viral inflammation, particularly in the context of COVID-19, can lead to a reduction in serotonin levels and contribute to the symptoms observed in Long COVID. It offers insights into potential therapeutic interventions targeting serotonin pathways to alleviate these symptoms. Read More: